Applied Therapeutics shares are trading higher after Leerink Partners initiated coverage on the stock with an Outperform rating and a $12 price target.
Portfolio Pulse from Benzinga Newsdesk
Applied Therapeutics' stock (APLT) is trading higher following an Outperform rating and a $12 price target from Leerink Partners.
February 22, 2024 | 4:44 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Applied Therapeutics' stock is experiencing a positive movement after receiving an Outperform rating and a $12 price target from Leerink Partners.
The Outperform rating and $12 price target set by Leerink Partners are strong indicators of the firm's positive outlook on Applied Therapeutics. This kind of analyst coverage often leads to increased investor interest and can drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100